Resources
Resources to help get your patients started on VYJUVEK
Filling out this form is the first step toward VYJUVEK treatment. It is the prescription form for VYJUVEK and enables patient enrollment into Krystal Connect.
Download NowThis guide provides general information on coding, coverage, billing, and reimbursement for VYJUVEK.
Download NowThis overview details the ordering and purchasing options for VYJUVEK.
Download NowA template you can use to request VYJUVEK prior to it being on formulary.
Download NowA template you can use as a reference when writing a Letter of Medical Necessity to your patient's insurance company.
Download NowA template you can use as a reference when writing a Letter of Appeal to your patient's insurance company requesting that it authorize coverage for VYJUVEK.
Download NowThis checklist will help navigate the process of submitting a Prior Authorization for VYJUVEK, should one be required.
Download NowA summary of the personalized patient support provided by the Krystal Connect Program and an overview of the steps to getting a patient started on VYJUVEK.
Download NowInformation about the preparation and administration of VYJUVEK
A brochure with step-by-step guidance on how to prepare VYJUVEK for administration.
Download NowThis brochure provides instructions on how to properly administer VYJUVEK to patients.
Download NowSee the steps necessary to mix and prepare VYJUVEK.
Watch a step-by-step demonstration of how to administer VYJUVEK to your patient's DEB wounds.
Real-World application video of VYJUVEK administered by Dr. Shireen Guide, on one of her DEB patients, Isaiah Z.
Helpful information to share with your patients or their caregivers about VYJUVEK and DEB
Information about VYJUVEK for DEB patients and their caregivers.
Download NowIntroduction to support services available to patients and their caregivers through Krystal Connect.
Download NowHear about real-world experience with VYJUVEK
Video Description FPO
Video Description FPO
1-844-5-KRYSTAL or connect with us.
Connect With Us
VYJUVEK is a topical gel indicated for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII (COL7A1) gene.
WARNINGS AND PRECAUTIONS
Accidental Exposure to VYJUVEK gel: VYJUVEK will not replicate in the subject’s cells and does not integrate into the subject cells’ native genetic material. For precautions, avoid direct contact with treated wounds (e.g., touching or scratching) and dressings of treated wounds for approximately 24 hours following treatment. Wear protective gloves when assisting subjects with changing wound dressings and handling the disposal. In the event of accidental exposure (e.g., through a splash to the eyes or mucous membranes), flush with clean water for at least 15 minutes.
Clean all surfaces that may have come in contact with VYJUVEK biological suspension or gel and treat all spills with a virucidal agent.
Dispose all materials (e.g., vial, syringe, needle, cleaning materials) that may have come in contact with VYJUVEK biological suspension or gel into a biohazard bag or container.
ADVERSE REACTIONSThe most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose.
- Please see Important Safety Information above and click here for full Prescribing Information.
VYJUVEK is a topical gel indicated for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII (COL7A1) gene.
WARNINGS AND PRECAUTIONS
Accidental Exposure to VYJUVEK gel: VYJUVEK will not replicate in the subject’s cells and does not integrate into the subject cells’ native genetic material. For precautions, avoid direct contact with treated wounds (e.g., touching or scratching) and dressings of treated wounds for approximately 24 hours following treatment. Wear protective gloves when assisting subjects with changing wound dressings and handling the disposal. In the event of accidental exposure (e.g., through a splash to the eyes or mucous membranes), flush with clean water for at least 15 minutes.
Clean all surfaces that may have come in contact with VYJUVEK biological suspension or gel and treat all spills with a virucidal agent.
Dispose all materials (e.g., vial, syringe, needle, cleaning materials) that may have come in contact with VYJUVEK biological suspension or gel into a biohazard bag or container.
ADVERSE REACTIONSThe most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose.
- Please see Important Safety Information above and click here for full Prescribing Information.
For US Healthcare Professionals Only
This website is intended for US healthcare professionals.
Would you like to continue?